Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vortioxetine for Freezing of Gait in Parkinson's Disease
NCT06805266Phase 4Not yet recruiting
- Start
- Feb 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of vortioxetine in Freezing of gait (FOG). Planned start Feb 2025; status: not yet recruiting.
02
Drugs
vortioxetine
03
Conditions
Freezing of gait (FOG)
Beyond the preview
Go deeper on NCT06805266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06805266.